Fernit's number was made up. 58% of Phase 3 trials are successful. Then:
The FDA estimates that only 25-30% of drugs in Phase 3 trials ultimately get approved3, which takes into account both the success of the trial itself and the subsequent regulatory review process.
Add to My Watchlist
What is My Watchlist?